International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Comparison of Two Doses of Dexmedetomidine as an Adjuvant to Bupivacaine 0.5% in USG Guided Supraclavicular Brachial Plexus Block: A Double Blind Randomised Controlled Study

Dr. Mohit Tanwar, Dr. Shailja Sharma, Dr. Sanjay Kumar Lal, Dr. Nikhil Vaid, Dr. Ankur Sehgal, Dr. Jayshree Kumari

Post Graduate Resident, Department of Anaesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India; Professor and HOD, Department of Anaesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India; Professor, Department of Anaesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India; Assistant Professor, Department of Anaesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India; Post Graduate Student, Department of Anaesthesia and Critical Care, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India

Article Information

Volume / Issue6 / 3 (July-September 2025)
Pages171-177
AccessOpen Access

Publication Timeline

  • Received07 June 2025
  • Accepted08 July 2025
  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Regional anesthesia has gained significant popularity in modern anesthetic practice due to its numerous advantages including superior postoperative analgesia, reduced opioid consumption, and minimal systemic side effects. The supraclavicular approach to brachial plexus block is considered the most effective technique for upper limb surgeries, providing dense anesthesia and analgesia. However, the duration of analgesia with local anesthetics alone is often insufficient for prolonged surgeries and postoperative pain management. Various adjuvants have been studied to enhance the quality and duration of regional blocks, with dexmedetomidine emerging as a promising option due to its unique pharmacological properties. This prospective, randomized, double-blind study was conducted to compare the efficacy of two different doses of dexmedetomidine (0.5 μg/kg and 1.0 μg/kg) when added to bupivacaine 0.5% in ultrasound-guided supraclavicular brachial plexus block. A total of 90 patients scheduled for elective upper limb surgeries were randomly allocated into three groups: Group C (control) received 30ml of 0.5% bupivacaine with normal saline, Group D1 received 30ml of 0.5% bupivacaine with 0.5 μg/kg dexmedetomidine, and Group D2 received 30ml of 0.5% bupivacaine with 1.0 μg/kg dexmedetomidine. Primary outcomes included onset and duration of sensory and motor blockade, while secondary outcomes comprised postoperative analgesia duration, total analgesic consumption, patient satisfaction scores, and adverse effects. Results demonstrated that both doses of dexmedetomidine significantly enhanced the quality of brachial plexus block compared to control, with faster onset times, prolonged duration of sensory and motor blockade, and extended postoperative analgesia. The higher dose (1.0 μg/kg) showed superior efficacy in terms of block duration and analgesic effect, though it was associated with increased incidence of sedation and bradycardia. Both dexmedetomidine groups showed significantly reduced postoperative analgesic requirements and higher patient satisfaction scores. The study concludes that dexmedetomidine 1.0 μg/kg provides optimal enhancement of bupivacaine-induced brachial plexus block, making it an excellent adjuvant for upper limb surgeries requiring prolonged anesthesia and analgesia.

Keywords

DexmedetomidineBupivacaineSupraclavicular blockBrachial plexusUltrasound guidanceRegional anesthesiaAdjuvant

References

  1. Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Leffert LR, Benzon HT. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med. 2018;43(3):263-309. [Google Scholar][Crossref]
  2. Tran DQ, Russo G, Muñoz L, Zaouter C, Finlayson RJ. A prospective, randomized comparison between ultrasound-guided supraclavicular, infraclavicular, and axillary brachial plexus blocks. Reg Anesth Pain Med. 2009;34(4):366-371. [Google Scholar][Crossref]
  3. Franco CD, Domashevich V, Voronov G, Bassin EJ, Sinha SK. The supraclavicular block with a nerve stimulator: to decrease or not to decrease, that is the question. Anesth Analg. 2004;98(4):1167-1171. [Google Scholar][Crossref]
  4. Sites BD, Chan VW, Neal JM, et al. The American Society of Regional Anesthesia and Pain Medicine and the European Society of Regional Anaesthesia and Pain Therapy joint committee recommendations for education and training in ultrasound-guided regional anesthesia. Reg Anesth Pain Med. 2010;35(2 Suppl):S74-80. [Google Scholar][Crossref]
  5. Kapral S, Krafft P, Eibenberger K, Fitzgerald R, Gosch M, Weinstabl C. Ultrasound-guided supraclavicular approach for regional anesthesia of the brachial plexus. Anesth Analg. 1994;78(3):507-513. [Google Scholar][Crossref]
  6. Brummett CM, Williams BA. Additives to local anesthetics for peripheral nerve blockade. Int Anesthesiol Clin. 2011;49(4):104-116. [Google Scholar][Crossref]
  7. Casati A, Putzu M. Bupivacaine, levobupivacaine and ropivacaine: are they clinically different? Best Pract Res Clin Anaesthesiol. 2005;19(2):247-268. [Google Scholar][Crossref]
  8. Covino BG. Pharmacology of local anaesthetic agents. Br J Anaesth. 1986;58(7):701-716. [Google Scholar][Crossref]
  9. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321(7275):1493. [Google Scholar][Crossref]
  10. Bailard NS, Ortega J, Flores RA. Additives to local anesthetics for peripheral nerve blocks: Evidence, limitations, and recommendations. Am J Health Syst Pharm. 2014;71(5):373-385. [Google Scholar][Crossref]
  11. Murphy DB, McCartney CJ, Chan VW. Novel analgesic adjuncts for brachial plexus block: a systematic review. Anesth Analg. 2000;90(5):1122-1128. [Google Scholar][Crossref]
  12. Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology. 2000;93(5):1345-1349. [Google Scholar][Crossref]
  13. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988;150(1-2):9-14. [Google Scholar][Crossref]
  14. Eisenach JC, De Kock M, Klimscha W. Alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology. 1996;85(3):655-674. [Google Scholar][Crossref]
  15. Brummett CM, Noeller HK, Gayraud-LaBat. Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in the rat. Anesthesiology. 2009;110(6):1283-1291. [Google Scholar][Crossref]
  16. Yoshitomi T, Kohjitani A, Maeda S, Higuchi H, Shimada M, Miyawaki T. Dexmedetomidine enhances the local anesthetic action of lidocaine via an alpha-2A adrenoceptor. Anesth Analg. 2008;107(1):96-101. [Google Scholar][Crossref]
  17. Swami SS, Keniya VM, Ladi SD, Rao R. Comparison of dexmedetomidine and clonidine (α2 agonist drugs) as an adjuvant to local anaesthesia in supraclavicular brachial plexus block: A randomised double-blind prospective study. Indian J Anaesth. 2012;56(3):243-249. [Google Scholar][Crossref]
  18. Marhofer D, Kettner SC, Marhofer P, Pils S, Weber M, Zeitlinger M. Dexmedetomidine as an adjuvant to ropivacaine prolongs peripheral nerve block: a volunteer study. Br J Anaesth. 2013;110(3):438-442. [Google Scholar][Crossref]
  19. Abdallah FW, Brull R. Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: a systematic review and meta-analysis. Br J Anaesth. 2013;110(6):915-925. [Google Scholar][Crossref]
  20. Vorobeichik L, Brull R, Abdallah FW. Evidence basis for using perineural dexmedetomidine to enhance the quality of brachial plexus nerve blocks: a systematic review and meta-analysis of randomized controlled trials. Br J Anaesth. 2017;118(2):167-181. [Google Scholar][Crossref]
  21. Kirksey MA, Haskins SC, Cheng J, Liu SS. Local anesthetic peripheral nerve block adjuvants for prolongation of analgesia: a systematic qualitative review. PLoS One. 2015;10(9):e0137312. [Google Scholar][Crossref]
  22. Huynh TM, Marret E, Bonnet F. Combination of dexmedetomidine and local anaesthetic solution in peripheral nerve blocks: A meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2018;35(1):6-15. [Google Scholar][Crossref]
  23. Kaur M, Singh PM. Current role of dexmedetomidine in clinical anesthesia and intensive care. Anesth Essays Res. 2011;5(2):128-133. [Google Scholar][Crossref]
  24. Brummett CM, Padda AK, Amodeo FS, Welch KB, Lydic R. Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. Anesthesiology. 2009;111(5):1111-1119. [Google Scholar][Crossref]
  25. Grape S, Kirkham KR, Frauenknecht J, Albrecht E. Intra-operative analgesia with remifentanil vs. dexmedetomidine: a systematic review and meta-analysis with trial sequential analysis. Anaesthesia. 2019;74(6):793-800. [Google Scholar][Crossref]

How to Cite

Tanwar, M., Sharma, S., Lal, S. K., Vaid, N., Sehgal, A., & Kumari, J. (2025). Comparison of Two Doses of Dexmedetomidine as an Adjuvant to Bupivacaine 0.5% in USG Guided Supraclavicular Brachial Plexus Block: A Double Blind Randomised Controlled Study. International Journal of Medical and All Body Health Research, 6(3), 171-177. https://doi.org/10.54660/IJMBHR.2025.6.3.171-177

Tanwar, Mohit, et al. "Comparison of Two Doses of Dexmedetomidine as an Adjuvant to Bupivacaine 0.5% in USG Guided Supraclavicular Brachial Plexus Block: A Double Blind Randomised Controlled Study." International Journal of Medical and All Body Health Research, vol. 6, no. 3, 2025, pp. 171-177. https://doi.org/10.54660/IJMBHR.2025.6.3.171-177.

Tanwar, M., Sharma, S., Lal, S. K., Vaid, N., Sehgal, A. and Kumari, J. (2025) 'Comparison of Two Doses of Dexmedetomidine as an Adjuvant to Bupivacaine 0.5% in USG Guided Supraclavicular Brachial Plexus Block: A Double Blind Randomised Controlled Study', International Journal of Medical and All Body Health Research, 6(3), pp. 171-177. doi: 10.54660/IJMBHR.2025.6.3.171-177.

Tanwar M, Sharma S, Lal SK, Vaid N, Sehgal A, Kumari J. Comparison of Two Doses of Dexmedetomidine as an Adjuvant to Bupivacaine 0.5% in USG Guided Supraclavicular Brachial Plexus Block: A Double Blind Randomised Controlled Study. International Journal of Medical and All Body Health Research. 2025;6(3):171-177. doi:10.54660/IJMBHR.2025.6.3.171-177

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.